Tetrasialoganglioside GQ1b (NH4+ salt)

CATALOG # 1516
Amount 100 µg
Price $245.00
Qty
 
Tetrasialoganglioside GQ1b (NH4+ salt)
  • Catalog #:1516
  • Scientific Name:Tetrasialoganglioside GQ1b (NH4+ salt)
  • Common Name:GQ1b
  • Empirical Formula:C106H182N6O55•4NH3 (stearoyl) Typical fatty acid content
  • CAS#68652-37-9
  • SDSView Safety Data Sheet
  • Data Sheet:View Data Sheet
  • Formula Weight:2421 +4NH3 (stearoyl)
  • Unit:100 µg
  • Source:natural
  • Purity:98+
  • Analytical Methods:TLC, identity confirmed by MS
  • Natural Source:bovine
  • Solubility:chloroform/methanol/water, 2:1:0.1; forms micellar solution in water
  • Physical Appearance:solid
  • Storage:-20°C
  • Dry Ice:No
  • Hazardous:No
  • Literature References:Application Notes:

    Gangliosides1 are acidic glycosphingolipids that form lipid rafts in the outer leaflet of the cell plasma membrane, especially in neuronal cells in the central nervous system.2 They participate in cellular proliferation, differentiation, adhesion, signal transduction, cell-to-cell interactions, tumorigenesis, and metastasis.3 The accumulation of gangliosides has been linked to several diseases including Tay-Sachs and Sandhoff disease while an autoimmune response against gangliosides can lead to Guillain-Barré syndrome. Miller-Fisher syndrome, a variant of Guillain-Barré syndrome, is an autoimmune disease characterized by the presence of anti-GQ1b ganglioside antibodies. Studies of these antibodies reveal large disruptions of Schwann cells. GQ1b has been shown to enhance Ig production of human peripheral blood mononuclear cells and to selectively enhance Th1 cytokine production while suppressing Th2 production. GQ1b has also been shown to enhance PHAinduced IL-2 secretion of peripheral blood T cells while it decreases PHA-induced IL-4 and IL-5 secretion. GQ1b suppresses PHA-induced increases in cAMP levels in T cells and suppresses PHA-stimulated adenylate cyclase activity in T cells.4

    References:
    1. L. Svennerholm, et al. (eds.), Structure and Function of Gangliosides, New York, Plenum, 1980
    2. T. Kolter, R. Proia, K. Sandhoff, Combinatorial Ganglioside Biosynthesis. J. Biol. Chem., July Vol. 277, No. 29, pp. 25859-25862, 2002
    3. S. Birkle, G. Zeng, L. Gao, R. K. Yu, and J. Aubry. Role of tumor-associated gangliosides in cancer progression. Biochimie, 85, 455–463, 2003
    4. N. Kanda and S. Watanabe “Gangliosides GD1b, GT1b, and GQ1b Enhance IL-2 and IFN-g Production and Suppress IL-4 and IL-5 Production in Phytohemagglutinin-Stimulated Human T Cells” The Journal of Immunology, Vol. 166 pp. 72-80, 2001